Anlon Healthcare Ltd vs Vadivarhe Speciality Chemicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 24, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 112.35 as of 24 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vadivarhe Speciality Chemicals Ltd changed from 30.6 on March 2023 to 0 on March 2025 . This represents a CAGR of -100.00% over 3 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Vadivarhe Speciality Chemicals Ltd changed from ₹ 16.11 crore on March 2021 to ₹ 33.55 crore on March 2025 . This represents a CAGR of 15.80% over 5 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of Vadivarhe Speciality Chemicals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of Vadivarhe Speciality Chemicals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of Vadivarhe Speciality Chemicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vadivarhe Speciality Chemicals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Vadivarhe Speciality Chemicals Ltd

Vadivarhe Speciality Chemicals Limited (VSCL) was incorporated on February 23, 2009 and prior to incorporation of the Company, Fem Care Pharma Ltd was promoted by the promoter Mr. Sunil Haripant Pophale which was later taken over by Dabur India Limited in 2009.
Mr. Sunil Haripant Pophale sold his stake in Fem Care Pharma Ltd to Dabur India Limited and as per the terms and condition of the Division Transfer Agreement dated May 07, 2009 the Speciality Chemical Division of Fem Care Pharma Limited was transferred to the Company as a going concern.
After the above transfer, the Company is running the Speciality Chemical Division under the leadership of the Promoter, Mr. Sunil Haripant Pophale. In 2010, the Company started API manufacturing.
In January-2011, Company started a Trading Business of Nutraceutical / Health Supplementary Products which was later discontinued effective from April 01, 2013.

FAQs for the comparison of Anlon Healthcare Ltd and Vadivarhe Speciality Chemicals Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Vadivarhe Speciality Chemicals Ltd?

Market cap of Anlon Healthcare Ltd is 597 Cr while Market cap of Vadivarhe Speciality Chemicals Ltd is 28 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Vadivarhe Speciality Chemicals Ltd?

The stock performance of Anlon Healthcare Ltd and Vadivarhe Speciality Chemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Vadivarhe Speciality Chemicals Ltd?

As of March 24, 2026, the Anlon Healthcare Ltd stock price is INR ₹112.35. On the other hand, Vadivarhe Speciality Chemicals Ltd stock price is INR ₹22.25.

How do dividend payouts of Anlon Healthcare Ltd and Vadivarhe Speciality Chemicals Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Vadivarhe Speciality Chemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.